These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32791353)

  • 1. Evaluation of novobiocin and telmisartan for anti-CHIKV activity.
    Tripathi PK; Soni A; Singh Yadav SP; Kumar A; Gaurav N; Raghavendhar S; Sharma P; Sunil S; Ashish ; Jayaram B; Patel AK
    Virology; 2020 Sep; 548():250-260. PubMed ID: 32791353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
    Akhrymuk I; Lukash T; Frolov I; Frolova EI
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification of chikungunya virus replication inhibitor validated using biochemical and cell-based approaches.
    Chaudhary M; Kumar A; Bala Sharma K; Vrati S; Sehgal D
    FEBS J; 2024 Jun; 291(12):2656-2673. PubMed ID: 38303163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease.
    Singh H; Mudgal R; Narwal M; Kaur R; Singh VA; Malik A; Chaudhary M; Tomar S
    Biochimie; 2018 Jun; 149():51-61. PubMed ID: 29635044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
    Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antivirals against the Chikungunya Virus.
    Battisti V; Urban E; Langer T
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phenotypic assay to identify Chikungunya virus inhibitors targeting the nonstructural protein nsP2.
    Lucas-Hourani M; Lupan A; Desprès P; Thoret S; Pamlard O; Dubois J; Guillou C; Tangy F; Vidalain PO; Munier-Lehmann H
    J Biomol Screen; 2013 Feb; 18(2):172-9. PubMed ID: 22983165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Validation of Novel Chikungunya Virus Protease Inhibitors.
    Das PK; Puusepp L; Varghese FS; Utt A; Ahola T; Kananovich DG; Lopp M; Merits A; Karelson M
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7382-7395. PubMed ID: 27736770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Strategies for Inhibition of Chikungunya Infection.
    Subudhi BB; Chattopadhyay S; Mishra P; Kumar A
    Viruses; 2018 May; 10(5):. PubMed ID: 29751486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.
    Wada Y; Orba Y; Sasaki M; Kobayashi S; Carr MJ; Nobori H; Sato A; Hall WW; Sawa H
    Virology; 2017 May; 505():102-112. PubMed ID: 28236746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of nsP2-specific nuclear functions attenuates chikungunya virus replication both in vitro and in vivo.
    Meshram CD; Lukash T; Phillips AT; Akhrymuk I; Frolova EI; Frolov I
    Virology; 2019 Aug; 534():14-24. PubMed ID: 31163352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
    Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
    Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapeutics for chikungunya virus.
    Ghildiyal R; Gabrani R
    Expert Opin Ther Pat; 2020 Jun; 30(6):467-480. PubMed ID: 32249636
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
    Pohjala L; Utt A; Varjak M; Lulla A; Merits A; Ahola T; Tammela P
    PLoS One; 2011; 6(12):e28923. PubMed ID: 22205980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antivirals against Chikungunya Virus: Is the Solution in Nature?
    Martins DOS; Santos IA; de Oliveira DM; Grosche VR; Jardim ACG
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32121393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of nobiletin against chikungunya virus in vitro.
    Lin SC; Chen MC; Li S; Lin CC; Wang TT
    Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of medicinal herbs for Anti-CHIKV activity.
    Raghavendhar S; Tripati PK; Ray P; Patel AK
    Virology; 2019 Jul; 533():45-49. PubMed ID: 31082733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral.
    Delang L; Segura Guerrero N; Tas A; Quérat G; Pastorino B; Froeyen M; Dallmeier K; Jochmans D; Herdewijn P; Bello F; Snijder EJ; de Lamballerie X; Martina B; Neyts J; van Hemert MJ; Leyssen P
    J Antimicrob Chemother; 2014 Oct; 69(10):2770-84. PubMed ID: 24951535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
    Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
    Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.